Analysed ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) News Sources
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Trump Prepares to Block Strait of Hormuz
13-04-2026
yahoo.com
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Amid Lingering Geopolitical Uncertainty, CPI Focus
10-04-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday as Fragile Middle East Ceasefire Lifts Oil Prices
09-04-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Amid Two-Week US-Iran Ceasefire
08-04-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Trump's Hormuz Reopening Deadline
07-04-2026
yahoo.com
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Monday Amid Ongoing Iran Conflict
06-04-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday as Escalation Signals in Iran Conflict Lift Oil Prices
02-04-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Gain Pre-Bell Wednesday as Iran War De-Escalation Hopes Drive Sentiment
01-04-2026
yahoo.com
What is the current price of ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ)?
The current price of ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) is $172.58.
ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) absolute price change since previous trading day?
The absolute price change of ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) since the previous trading day is $3.21.
ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) percentage price change since previous trading day?
The percentage price change of ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) since the previous trading day is 1.8953%.
What is the most recent average sentiment score for ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ)?
The most recent average sentiment score for ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) is 55 out of 100.
What is the most recent average sentiment for ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ)?
The most recent sentiment for ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ) is .
SEC-8K** Filing Available For ISHARES BIOTECHNOLOGY ETF (IBB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.